Home » Topics » BioWorld Science

BioWorld Science
RSS

Inozyme introduces genetic testing program for two rare calcification disorders

June 15, 2018

FDA confirms regulatory pathway for Resverlogix's apabetalone

June 15, 2018

FDA awards RMAT designation to Nightstar's NSR-REP1 for choroideremia

June 15, 2018

[177Lu]3BP-227 begins phase I/II trial in advanced solid tumors expressing NTSR1

June 15, 2018

Trillium initiates phase I trial of TTI-622 in lymphoma or myeloma

June 15, 2018

Responses seen with NY-ESO SPEAR T-cells in myxoid/round cell liposarcoma

June 15, 2018

BioClin Therapeutics presents first data from FIERCE-21 trial of B-701 plus docetaxel in mUCC

June 15, 2018

Eisai subsidiary in joint nucleic acid drug discovery research program

June 15, 2018

Arsanis outlicenses monoclonal antibodies targeting Klebsiella pneumoniae

June 15, 2018

First participant dosed in phase II study of vosoritide in infants and young children

June 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...